EF
PCRX icon

Empowered Funds’s Pacira BioSciences PCRX Stock Holding History

Empowered Funds’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.26M Buy
+276,776
New +$6.15M 0.04% 554
2025
Q4 		– Sell
-223,438
Closed -$5.76M – 1654
2025
Q3 		$5.76M Sell
223,438
-15,535
-7% -$382K 0.06% 436
2025
Q2 		$5.71M Buy
238,973
+4,744
+2% +$120K 0.06% 401
2025
Q1 		$5.82M Buy
234,229
+4,744
+2% +$114K 0.08% 336
2024
Q4 		$4.32M Buy
229,485
+11,149
+5% +$196K 0.06% 419
2024
Q3 		$3.29M Buy
+218,336
New +$3.73M 0.05% 499

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return